Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Ferring International Center SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Ferring International Center SA, Medical Devices Deals, 2011 to YTD 2017 10
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Ferring International Center SA, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Ferring International Center Acquire Ex-US Vitaros Assets and Rights from Apricus Biosciences 13
Ferring Pharma Acquires Global Rights to Milprosa from Teva Women’s Health 15
Ferring Pharma to Acquire Novel Drug Delivery Technology from CTCBIO 16
Ferring Pharma Acquires Assets from BioSurface Engineering 17
Ferring Pharma Acquires Ddavp from Sanofi 18
Ferring International To Acquire Assets Of Al-Kindi Pharma For US$6 Million 19
Partnerships 20
LIDDS Enters into Research Agreement with Ferring Pharma 20
Ferring International and Alrise Biosystems Enter into Co-Development Agreement 21
Ferring Pharma Enters into Agreement with CD Investments 22
Ferring Pharma Enters into Partnership with ICF 23
Ferring Pharma Enters into Agreement with Intralytix 24
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 25
Ferring Pharma Enters into Co-Development Agreement with Karolinska Institutet 26
Apricus Biosciences Extends Distribution Agreement with Ferring Pharma 27
Ferring Pharma Enters into Co-Development Agreement with Roche 28
Ferring Pharma And Merck Enter Into Agreement With World Health Organization For Anti-Bleeding Drug 29
Ferring Pharma Enters Into Co-Promotion Agreement With Kyowa Hakko For Desmopressin Acetate 30
Licensing Agreements 31
Ferring International Enters into Licensing Agreement with Enteris BioPharma 31
Ferring International Enters into Licensing Agreement with IMAB 32
Ferring Pharma Enters into Licensing Agreement with Seikagaku 33
Ferring Pharma Enters into Licensing Agreement with Cosmo Pharma 34
Levo Therapeutics to Enter into Licensing Agreement with Ferring Pharma 35
TxCell Enters into Licensing Agreement with Ferring International for Ovasave 36
SciGen Expands Its Licensing Agreement With Ferring And Bio-Technology General 38
Acquisition 39
Ferring Pharma Acquires Cytokine PharmaSciences And Controlled Therapeutics 39
Ferring International Center SA – Key Competitors 40
Ferring International Center SA – Key Employees 41
Ferring International Center SA – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 47
Corporate Communications 47
Oct 02, 2017: Ferring appoints Klaus Dugi as Executive Vice President and Chief Medical Officer 47
May 23, 2017: Ferring commits $10 million to March of Dimes to expand research needed to end preterm birth 48
Apr 03, 2017: Ferring appoints Dominic Moorhead as Executive Vice President and Chief Financial Officer 49
Government and Public Interest 50
Jun 21, 2016: Ferring demonstrates commitment to R&D investment through expanded Innovation Grants Program 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51
Ferring International Center SA, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Ferring International Center SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Ferring International Center SA, Deals By Therapy Area, 2011 to YTD 2017 9
Ferring International Center SA, Medical Devices Deals, 2011 to YTD 2017 10
Ferring International Center SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Ferring International Center Acquire Ex-US Vitaros Assets and Rights from Apricus Biosciences 13
Ferring Pharma Acquires Global Rights to Milprosa from Teva Women's Health 15
Ferring Pharma to Acquire Novel Drug Delivery Technology from CTCBIO 16
Ferring Pharma Acquires Assets from BioSurface Engineering 17
Ferring Pharma Acquires Ddavp from Sanofi 18
Ferring International To Acquire Assets Of Al-Kindi Pharma For US$6 Million 19
LIDDS Enters into Research Agreement with Ferring Pharma 20
Ferring International and Alrise Biosystems Enter into Co-Development Agreement 21
Ferring Pharma Enters into Agreement with CD Investments 22
Ferring Pharma Enters into Partnership with ICF 23
Ferring Pharma Enters into Agreement with Intralytix 24
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 25
Ferring Pharma Enters into Co-Development Agreement with Karolinska Institutet 26
Apricus Biosciences Extends Distribution Agreement with Ferring Pharma 27
Ferring Pharma Enters into Co-Development Agreement with Roche 28
Ferring Pharma And Merck Enter Into Agreement With World Health Organization For Anti-Bleeding Drug 29
Ferring Pharma Enters Into Co-Promotion Agreement With Kyowa Hakko For Desmopressin Acetate 30
Ferring International Enters into Licensing Agreement with Enteris BioPharma 31
Ferring International Enters into Licensing Agreement with IMAB 32
Ferring Pharma Enters into Licensing Agreement with Seikagaku 33
Ferring Pharma Enters into Licensing Agreement with Cosmo Pharma 34
Levo Therapeutics to Enter into Licensing Agreement with Ferring Pharma 35
TxCell Enters into Licensing Agreement with Ferring International for Ovasave 36
SciGen Expands Its Licensing Agreement With Ferring And Bio-Technology General 38
Ferring Pharma Acquires Cytokine PharmaSciences And Controlled Therapeutics 39
Ferring International Center SA, Key Competitors 40
Ferring International Center SA, Key Employees 41
Ferring International Center SA, Other Locations 43
Ferring International Center SA, Subsidiaries 43